Half-year report · Q2
7446.TEDINET S100VQQA
Period2024-10-01 → 2025-03-31
Filed2025-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥17.8bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥32.2bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.6bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥325m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥276m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥355m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥408m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥302m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥400m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥314m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥269m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥237m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥211m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥273m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥213m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥18.5bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥17.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥19.8bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.8bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥9.7bn | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.5bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.6bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥764m | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥745m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥674m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.0bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥226m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥62m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥108m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥54m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥6m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥210m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥83m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥298.4 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥263.54 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥233.86 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 40.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 16
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02810-000Academia Life Science Sales Groupreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥1.5bn |
| jpcrp040300-q2r_E02810-000Academia Life Science Sales Groupreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥1.5bn |
| jpcrp040300-q2r_E02810-000Industry Sales Groupreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥9.1bn |
| jpcrp040300-q2r_E02810-000Industry Sales Groupreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥9.1bn |
| jpcrp040300-q2r_E02810-000Medical Sales Groupreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥7.2bn |
| jpcrp040300-q2r_E02810-000Medical Sales Groupreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥7.2bn |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥17.8bn |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥17.8bn |
| jpcrp040300-q2r_E02810-000Academia Life Science Sales Groupreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥1.2bn |
| jpcrp040300-q2r_E02810-000Academia Life Science Sales Groupreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥1.2bn |
| jpcrp040300-q2r_E02810-000Industry Sales Groupreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥8.3bn |
| jpcrp040300-q2r_E02810-000Industry Sales Groupreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥8.3bn |
| jpcrp040300-q2r_E02810-000Medical Sales Groupreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E02810-000Medical Sales Groupreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥7.1bn |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥16.6bn |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥16.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 508
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration | 276039000 | JPY |
| Operating income | CurrentYTDDuration | 325036000 | JPY |
| Interest income noi | Prior1YTDDuration | 1179000 | JPY |
| Interest income noi | CurrentYTDDuration | 2403000 | JPY |
| Dividends income noi | Prior1YTDDuration | 20470000 | JPY |
| Dividends income noi | CurrentYTDDuration | 24212000 | JPY |
| Commission fee noi | Prior1YTDDuration | 6573000 | JPY |
| Commission fee noi | CurrentYTDDuration | 5062000 | JPY |
| Miscellaneous income noi | Prior1YTDDuration | 2368000 | JPY |
| Miscellaneous income noi | CurrentYTDDuration | 4233000 | JPY |
| Other noi | Prior1YTDDuration | 891000 | JPY |
| Other noi | CurrentYTDDuration | 128000 | JPY |
| Non operating income | Prior1YTDDuration | 31484000 | JPY |
| Non operating income | CurrentYTDDuration | 36039000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 1168000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 2002000 | JPY |
| Commission fee noe | Prior1YTDDuration | 379000 | JPY |
| Commission fee noe | CurrentYTDDuration | 2858000 | JPY |
| Bad debts expenses noe | Prior1YTDDuration | 2140000 | JPY |
| Bad debts expenses noe | CurrentYTDDuration | － | JPY |
| Miscellaneous loss noe | Prior1YTDDuration | 1206000 | JPY |
| Miscellaneous loss noe | CurrentYTDDuration | 667000 | JPY |
| Loss on investments in partnership noe | Prior1YTDDuration | 645000 | JPY |
| Loss on investments in partnership noe | CurrentYTDDuration | 580000 | JPY |
| Non operating expenses | Prior1YTDDuration | 5539000 | JPY |
| Non operating expenses | CurrentYTDDuration | 6109000 | JPY |
| Ordinary income | Prior1YTDDuration | 301984000 | JPY |
| Ordinary income | CurrentYTDDuration | 354966000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | 14904000 | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | － | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | － | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 45506000 | JPY |
| Extraordinary income | Prior1YTDDuration | 14904000 | JPY |
| Extraordinary income | CurrentYTDDuration | 45506000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 3203000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 148000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 3203000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 148000 | JPY |
| Income before income taxes | Prior1YTDDuration | 313685000 | JPY |
| Income before income taxes | CurrentYTDDuration | 400325000 | JPY |
| Income taxes current | Prior1YTDDuration | 98986000 | JPY |
| Income taxes current | CurrentYTDDuration | 117374000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 2133000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 10369000 | JPY |
| Income taxes | Prior1YTDDuration | 101119000 | JPY |
| Income taxes | CurrentYTDDuration | 127744000 | JPY |
| Profit loss | Prior1YTDDuration | 212565000 | JPY |
| Profit loss | CurrentYTDDuration | 272580000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 1851000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 3728000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |